Oppenheimer & CO Inc Invitae Corp Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$0.6 - $1.53 $9,900 - $25,245	-16,500 Reduced 57.09%	12,400 $7,000
Q2 2023 Aug 02, 2023	BUY	$1.05 - $1.63 $10,762 - $16,707	10,250 Added 54.96%	28,900 $32,000
Q1 2023 May 10, 2023	BUY	$1.2 - $2.73 $2,880 - $6,552	2,400 Added 14.77%	18,650 $25,000
Q4 2022 Feb 07, 2023	BUY	$1.71 - $3.61 $4,446 - $9,386	2,600 Added 19.05%	16,250 $30,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $2,660 - $12,082	1,400 Added 11.43%	13,650 $34,000
Q2 2022 Aug 08, 2022	BUY	$2.13 - $9.01 $26,092 - $110,372	12,250 New	12,250 $30,000
Q1 2022 May 12, 2022	SELL	$6.28 - $15.59 $358,500 - $889,970	-57,086 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$14.7 - $28.67 $13,729 - $26,777	-934 Reduced 1.61%	57,086 $872,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $93,885 - $129,763	3,862 Added 7.13%	58,020 $1.65 Million
Q2 2021 Aug 03, 2021	SELL	$26.09 - $40.4 $242,428 - $375,396	-9,292 Reduced 14.64%	54,158 $1.83 Million
Q1 2021 May 10, 2021	SELL	$33.06 - $56.93 $203,649 - $350,688	-6,160 Reduced 8.85%	63,450 $2.42 Million
Q4 2020 Feb 11, 2021	BUY	$39.09 - $57.4 $841,216 - $1.24 Million	21,520 Added 44.75%	69,610 $2.91 Million
Q3 2020 Nov 13, 2020	SELL	$28.43 - $44.67 $1.15 Million - $1.81 Million	-40,489 Reduced 45.71%	48,090 $2.08 Million
Q2 2020 Aug 11, 2020	SELL	$11.71 - $30.29 $584,387 - $1.51 Million	-49,905 Reduced 36.04%	88,579 $2.68 Million
Q1 2020 May 08, 2020	BUY	$7.64 - $27.5 $615,936 - $2.22 Million	80,620 Added 139.33%	138,484 $1.89 Million
Q4 2019 Feb 07, 2020	SELL	$15.02 - $20.57 $425,801 - $583,138	-28,349 Reduced 32.88%	57,864 $933,000
Q3 2019 Oct 31, 2019	BUY	$18.85 - $27.5 $774,282 - $1.13 Million	41,076 Added 91.0%	86,213 $1.66 Million
Q2 2019 Aug 09, 2019	BUY	$17.37 - $26.27 $784,029 - $1.19 Million	45,137 New	45,137 $1.06 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account